5 clinics across New York · Virtual consultations available
PCOS symptoms vary dramatically from woman to woman. Learn how the four PCOS phenotypes influence hormone levels, fertility, ovulation, metabolism, and treatment responses.
PCOS is often treated as a single condition, but research shows it is actually a spectrum of different hormonal and metabolic phenotypes. Learn why personalized care may be the future of PCOS treatment and fertility support.
Not all PCOS presents the same way. Learn how identifying your specific PCOS phenotype may help guide more personalized approaches to fertility, hormone health, metabolic wellness, and symptom management.
PCOS is not a one-size-fits-all condition. Learn about the four PCOS phenotypes, how symptoms differ between women, and why identifying your specific type may help guide more personalized fertility and hormone support.
A newly proposed federal fertility policy could expand access to IVF and fertility treatment by allowing employers to offer stand-alone fertility benefits outside traditional insurance plans. Learn what this proposal could mean for reproductive healthcare and family planning.
New fertility research exploring NAD and NMN supplementation is giving scientists hope that age-related fertility decline may one day become more treatable. Learn how this emerging science could reshape reproductive wellness and ovarian aging research.
Artificial intelligence is changing the future of fertility care through AI-powered IVF technology, embryo analysis, and advanced sperm detection systems. Learn how these innovations are helping more individuals and couples pursue parenthood with new hope.
As fertility changes with age, cellular health becomes increasingly important. Learn how NAD+, glutathione, mitochondrial function, and oxidative stress influence ovarian health and egg quality over time.
Cellular health plays a major role in fertility, especially when it comes to egg quality, mitochondrial function, NAD+, and oxidative stress. Learn how energy production and antioxidant protection work together to support reproductive health.
NAD+ is becoming a growing topic in fertility and wellness conversations as women explore proactive ways to support egg quality, mitochondrial health, and reproductive wellness. Here is why interest in NAD+ therapy and supplementation continues to rise.
NAD+ supplements are moving beyond anti-aging and into beauty, recovery, and general wellness, especially among younger consumers. Here is what is driving that shift and why interest is growing faster than clinical certainty.
New research in a mouse model of Wilson disease suggests glutathione may help protect sperm production by reducing oxidative stress, mitochondrial damage, and cell death. Here is what that may mean, and what it does not yet prove, for male fertility.
Egg count matters, but egg quality often matters just as much when it comes to fertilization, embryo development, and pregnancy potential. Here is what egg quality actually means and how cellular health, oxidative stress, and age fit into the picture.
NAD+ and glutathione both play important roles in cellular health, and those roles matter in fertility too. Here is how mitochondrial energy and antioxidant protection intersect with egg quality, ovarian aging, and reproductive health.
Mini-IVF uses less medication than conventional IVF and aims for fewer eggs with a lower treatment burden. Here is how the protocol works, why some clinics use clomiphene citrate and freeze-all strategies, and what tradeoffs patients should understand.
Embryo arrest happens when a fertilized egg stops developing before the blastocyst stage. Here is what that can mean in IVF, what factors may contribute, and how patients can think about next steps with clearer expectations.
ICSI is a specialized form of IVF that may help when sperm-related fertility barriers make fertilization harder. Here is what the procedure does, why it may be recommended, and what it can and cannot change.
A breast cancer diagnosis can move quickly, but fertility should not become an afterthought. Early counseling and referral can help preserve options before treatment begins and reduce avoidable regret later.
GLP-1 medications such as semaglutide and tirzepatide are not fertility drugs, but they may indirectly improve ovulation and fertility for some patients, especially those with PCOS or metabolic dysfunction. Here is what that may mean for planning, contraception, and pregnancy.
Falling birth rates are often framed as an economic problem, but some commentators argue that culture, family messaging, and social expectations play an even bigger role. Here is how that debate connects to real family-building decisions.
The global market for infertility treatment devices is expected to grow through 2035, driven by rising demand, IVF expansion, and new lab technologies. Here is what that trend may mean for patients and where its limits still matter.
Elizabeth Carr’s story offers a powerful look at how IVF moved from public uncertainty to a life-changing family-building option, and why outdated myths about the treatment still deserve correction.
Sara Pascoe’s reflections on IVF highlight how physically and emotionally demanding fertility treatment can be, and why public honesty about that experience can help reduce isolation for others.
When someone you care about is facing infertility, the most helpful text is often the one that makes them feel seen, safe, and not pressured to perform hope. Here is how to offer support with empathy and without unsolicited advice.
